CASPR Technologies – is the sister company of ReSPR Technologies. The latter had since 2000 a strong history in the development of NCC Technology and its application in industrial and medical settings in Europe, LATAM, SE Asia, and ANZ
CASPR Technologies is a purpose-driven business that commenced in 2015 in the USA.Its principal focus was to take the lessons learned from ReSPR and apply them to the health sector.
The third plank in Airandé’s approach to disinfection is continuous air and surface purification. To achieve this, Airandé is the exclusive distributor in Australia, New Zealand, and Belgium of the built-for-purpose CASPR range of NCC air purification technologies. The CASPR NCC is the next generation of PCO technology that captures particles of 0.001 microns in size compared with HEPA filters that capture particles of 0.1 microns or larger.
NCC is an acronym for Natural Catalytic Conversion. By using patented technology, NCC produces H2O2 continuously at a level of 0.03ppm. Way inside global safety standards – and no more than the concentration of H2O2 that is found in nature.
The benefits of the CASPR technology are it removes (i) pathogens from the air and from all of the surfaces in the rooms and spaces where it is used, and (ii) it increases the ventilation in that space.
The CASPR medical grade air and surface purification system is distributed by Airandé. When used in US hospitals it has been shown to remove all pathogens linked to hospital acquired infections. As a result, these have been reduced dramatically as a result. And, hospital staff absenteeism has also been cut.
Airandé and its partners have installed the CASPR technologies in hospitals, ambulances, and emergency vehicles.
